Dermatology Articles

• Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain July 30, 2026
  The selective NaV1.8 inhibitor LTG-001 led to significantly greater reductions in pain scores than placebo over the course of 48 hours among patients who had moderate or severe pain after abdominoplasty.
  Neil Singla, Nathaniel P. Katz, Ben Vaughn, Timothy Rogier, Todd Bertoch, Harold Minkowitz, Mallory Loflin
• Koebner Phenomenon from Wet Cupping July 23, 2026
  A 35-year-old man with well-controlled plaque psoriasis presented with new skin lesions. Two weeks earlier, he had undergone wet cupping. Physical examination revealed erythematous, scaly papules and plaques on his back.
  Yusuf Demir, Zekayi Kutlubay
• Targeted Degradation of NETs in Lupus with DNASE1L3 Deficiency July 16, 2026
  Recombinant DNASE1L3 therapy reduced symptoms in a patient with severe lupus with DNASE1L3 deficiency. Antidrug antibodies caused effects to wane, but findings support NET-targeted therapy as a nonimmunosuppressive approach.
  Tadej Avčin, Andreas Reiff, Maša Bizjak, Barbara Jenko Bizjan, Tina Vesel Tajnšek, Maruša Debeljak, Tyler Artner, Bernd Jilma, Christian Lood, Abdul Hakkim, Tobias A. Fuchs